7210Research and experimental development on natural sciences and engineering

866 companies

This activity has special requirements (e.g. a licence or notice).

Sub-industries

72101Research and experimental development on natural sciences and engineering866

Largest companies by revenue

1.Starship Technologies OÜ
12673365, Mustamäe linnaosa
Revenue 2025
€22.2M
+15%
Net profit
€962K
−2.5%
Employees
193
2.Diotech OÜ
12672325, Tartu linn
Revenue 2025
€10.6M
−43%
Net profit
€222.4K
−87%
Employees
22
3.Icosagen Cell Factory OÜ
11107818, Õssu küla
Revenue 2025
€8.8M
−32%
Net profit
−€4.4M
−617%
Employees
182
4.OÜ Kliiniliste Uuringute Keskus
11497084, Tartu linn
Revenue 2025
€4.4M
−37%
Net profit
€346.9K
−83%
Employees
18
5.OÜ Cambrex Tallinn
10396298, Mustamäe linnaosa
Revenue 2025
€3.4M
−9%
Net profit
€102.2K
−72%
Employees
42
6.IQVIA RDS Estonia OÜ
10680941, Tartu linn
Revenue 2025
€3.3M
+2.2%
Net profit
€197.4K
+10%
Employees
41
7.Bisly OÜ
12198160, Põhja-Tallinna linnaosa
Revenue 2025
€3.3M
+64%
Net profit
−€1.5M
+26%
Employees
35
8.PSI CRO OSAÜHING
11357857, Kesklinna linnaosa
Revenue 2025
€3.1M
+1.4%
Net profit
€96.9K
+9.4%
Employees
30
9.Attarat Holding OÜ
12894095, Kesklinna linnaosa
Revenue 2025
€2.6M
−7.6%
Net profit
−€7.3M
−25%
Employees
0
10.Icosagen AS
10565884, Õssu küla
Revenue 2025
€2.1M
+4.4%
Net profit
€132.7K
+11%
Employees
38

#	Company	Reg.	Revenue	Change	Net profit	Change	Employees
1	Starship Technologies OÜ 12673365, Mustamäe linnaosa	2014	€22,235,015 2025	+15%	€962,003	−2.5%	193 annual average (FTE)
2	Diotech OÜ 12672325, Tartu linn	2014	€10,564,558 2025	−43%	€222,418	−87%	22 at quarter end
3	Icosagen Cell Factory OÜ 11107818, Õssu küla	2005	€8,771,543 2025	−32%	−€4,384,364	−617%	182 annual average (FTE)
4	OÜ Kliiniliste Uuringute Keskus 11497084, Tartu linn	2008	€4,429,465 2025	−37%	€346,855	−83%	18 annual average (FTE)
5	OÜ Cambrex Tallinn 10396298, Mustamäe linnaosa	1998	€3,380,902 2025	−9%	€102,158	−72%	42 annual average (FTE)
6	IQVIA RDS Estonia OÜ 10680941, Tartu linn	2000	€3,341,327 2025	+2.2%	€197,425	+10%	41 annual average (FTE)
7	Bisly OÜ 12198160, Põhja-Tallinna linnaosa	2011	€3,292,846 2025	+64%	−€1,483,357	+26%	35 annual average (FTE)
8	PSI CRO OSAÜHING 11357857, Kesklinna linnaosa	2007	€3,108,620 2025	+1.4%	€96,857	+9.4%	30 annual average (FTE)
9	Attarat Holding OÜ 12894095, Kesklinna linnaosa	2015	€2,604,416 2025	−7.6%	−€7,334,463	−25%	0 annual average (FTE)
10	Icosagen AS 10565884, Õssu küla	1999	€2,124,539 2025	+4.4%	€132,737	+11%	38 at quarter end

Includes

This class includes: - research and experimental development on natural sciences and engineering: • research and development on natural sciences • research and development on engineering and technology • research and development on medical, health and life, and veterinary sciences • research and development on biotechnology • research and development on agricultural, forestry and fisheries sciences • interdisciplinary research and development, predominantly on natural sciences and engineering This class also includes: - DNA sequencing for general research on biological processes

Excludes

DNA sequencing for ruling out or curing a specific disease, see 8691